tiprankstipranks
Marker Therapeutics (MRKR)
:MRKR
US Market

Marker Therapeutics (MRKR) Income Statement

Compare
515 Followers

Marker Therapeutics Income Statement

Last quarter (Q3 2024), Marker Therapeutics's total revenue was $1.93M, an increase of 647.66% from the same quarter last year. In Q3, Marker Therapeutics's net income was $-2.31M. See Marker Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.31M$ 9.00M$ 1.24M$ 466.79K$ 213.19K
Gross Profit
$ -7.11M$ 5.32M$ -1.92M$ -18.41M$ -12.55M
Operating Expenses
$ 7.48M$ 38.96M$ 40.72M$ 29.35M$ 22.74M
Depreciation and Amortization
$ 2.79M$ 3.68M$ 3.16M$ 1.08M$ 286.58K
EBITDA
$ -11.79M$ -19.79M$ -36.32M$ -27.63M$ -22.03M
Operating Income
$ -14.58M$ -29.95M$ -39.48M$ -28.89M$ -22.53M
Other Income/Expenses
$ 539.16K$ 15.09K$ -2.40M$ 179.74K$ 1.10M
Pretax Income
$ -14.04M$ -29.93M$ -41.88M$ -28.71M$ -21.43M
Net Income
$ -14.05M$ -29.92M$ -41.87M$ -28.53M$ -20.33M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.93$ -3.58$ -5.47$ -6.06$ -4.46
Diluted EPS
$ -1.93$ -3.58$ -5.47$ -6.06$ -4.46
Weighted Average Shares Outstanding
8.81M 8.35M 7.65M 4.70M 4.56M
Weighted Average Shares Outstanding (Diluted)
8.81M 8.35M 7.65M 4.70M 4.56M
Currency in USD

Marker Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis